NO20024853L - Fremgangsmate for seleksjon og testing av forbindelser som inhiberer klonal cellevekst og anvendelse av slike forbindelser - Google Patents
Fremgangsmate for seleksjon og testing av forbindelser som inhiberer klonal cellevekst og anvendelse av slike forbindelserInfo
- Publication number
- NO20024853L NO20024853L NO20024853A NO20024853A NO20024853L NO 20024853 L NO20024853 L NO 20024853L NO 20024853 A NO20024853 A NO 20024853A NO 20024853 A NO20024853 A NO 20024853A NO 20024853 L NO20024853 L NO 20024853L
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- selecting
- methods
- cell growth
- clonal cell
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO20024853A NO326130B1 (no) | 2002-10-08 | 2002-10-08 | Fremgangsmate for seleksjon og testing av forbindelser som inhiberer eller stimulerer klonal cellevekst |
CA002501039A CA2501039A1 (en) | 2002-10-08 | 2003-10-07 | Method for selection of compounds which inhibit clonal cell growth and use thereof |
EP03811277.7A EP1549742B1 (en) | 2002-10-08 | 2003-10-07 | Method for selection of compounds which inhibit clonal cell growth and use thereof |
PCT/NO2003/000335 WO2004055175A1 (en) | 2002-10-08 | 2003-10-07 | Method for selection of compounds which inhibit clonal cell growth and use thereof |
AU2003302154A AU2003302154B2 (en) | 2002-10-08 | 2003-10-07 | Method for selection of compounds which inhibit clonal cell growth and use thereof |
US10/530,488 US20060121449A1 (en) | 2002-10-08 | 2003-10-07 | Method for selection of compounds which inhibit clonal cell growth and use thereof |
ZA200502609A ZA200502609B (en) | 2002-10-08 | 2005-03-31 | Method for selection of compounds which inhibit clonal call growth and use thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO20024853A NO326130B1 (no) | 2002-10-08 | 2002-10-08 | Fremgangsmate for seleksjon og testing av forbindelser som inhiberer eller stimulerer klonal cellevekst |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20024853D0 NO20024853D0 (no) | 2002-10-08 |
NO20024853L true NO20024853L (no) | 2004-04-13 |
NO326130B1 NO326130B1 (no) | 2008-10-06 |
Family
ID=19914079
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20024853A NO326130B1 (no) | 2002-10-08 | 2002-10-08 | Fremgangsmate for seleksjon og testing av forbindelser som inhiberer eller stimulerer klonal cellevekst |
Country Status (7)
Country | Link |
---|---|
US (1) | US20060121449A1 (no) |
EP (1) | EP1549742B1 (no) |
AU (1) | AU2003302154B2 (no) |
CA (1) | CA2501039A1 (no) |
NO (1) | NO326130B1 (no) |
WO (1) | WO2004055175A1 (no) |
ZA (1) | ZA200502609B (no) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0317268D0 (en) * | 2003-07-23 | 2003-08-27 | Viral Asa A | Compounds |
EP2368558A1 (en) * | 2010-03-23 | 2011-09-28 | Mdc Max-Delbrück-Centrum Für Molekulare Medizin Berlin - Buch | Azo compounds reducing formation and toxicity of amyloid beta aggregation intermediates |
US10976320B2 (en) * | 2013-05-21 | 2021-04-13 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for identifying and treating cancer patients |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4744985A (en) * | 1979-08-24 | 1988-05-17 | Toyama Chemical Co., Ltd. | Novel substances having carcinostatic and immunostimulating activity, process for preparing the same and carcinostatic agent containing the same |
JPH0610141B2 (ja) * | 1986-02-14 | 1994-02-09 | 新技術事業団 | エイズウイルス性疾患処置剤 |
US5597798A (en) * | 1990-03-05 | 1997-01-28 | The Regents Of The University Of California | Taxol and epidermal growth factor used to enhance treatment of ovarian cancer |
US5639600A (en) * | 1994-08-05 | 1997-06-17 | The Regents Of The University Of California | Diagnosis and treatment of cell proliferative disease having clonal macrophage involvement |
US5674888A (en) * | 1995-06-07 | 1997-10-07 | University Of California | Method for the treatment of a trabecular meshwork whose cells are subject to inhibition of cell division |
JP3190011B2 (ja) * | 1997-05-23 | 2001-07-16 | ローム株式会社 | 強誘電体記憶素子およびその製造方法 |
AU754864B2 (en) * | 1998-03-28 | 2002-11-28 | Arizona Board Of Regents On Behalf Of The University Of Arizona, The | DFMO and sulindac combination in cancer chemoprevention |
US6201028B1 (en) * | 1998-12-08 | 2001-03-13 | The Rockefeller University | Methods and compositions for prevention and treatment of atherosclerosis and hyperlipidemia with non-steroidal anti-inflammatory drugs |
GB9915184D0 (en) * | 1999-06-29 | 1999-09-01 | Viral As A | Compounds |
KR20060031809A (ko) * | 2003-06-09 | 2006-04-13 | 더 리젠츠 오브 더 유니버시티 오브 미시간 | 암 치료 및 진단용 조성물 및 방법 |
-
2002
- 2002-10-08 NO NO20024853A patent/NO326130B1/no not_active IP Right Cessation
-
2003
- 2003-10-07 EP EP03811277.7A patent/EP1549742B1/en not_active Expired - Lifetime
- 2003-10-07 US US10/530,488 patent/US20060121449A1/en not_active Abandoned
- 2003-10-07 WO PCT/NO2003/000335 patent/WO2004055175A1/en not_active Application Discontinuation
- 2003-10-07 AU AU2003302154A patent/AU2003302154B2/en not_active Ceased
- 2003-10-07 CA CA002501039A patent/CA2501039A1/en not_active Abandoned
-
2005
- 2005-03-31 ZA ZA200502609A patent/ZA200502609B/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2003302154B2 (en) | 2008-06-12 |
NO20024853D0 (no) | 2002-10-08 |
WO2004055175A1 (en) | 2004-07-01 |
CA2501039A1 (en) | 2004-07-01 |
NO326130B1 (no) | 2008-10-06 |
EP1549742B1 (en) | 2014-01-08 |
AU2003302154A1 (en) | 2004-07-09 |
ZA200502609B (en) | 2006-07-26 |
US20060121449A1 (en) | 2006-06-08 |
EP1549742A1 (en) | 2005-07-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1499311T3 (da) | Substituerede benzaboler og anvendelse deraf som RAF-kinaseinhibitorer | |
NO20044095L (no) | 5-fenyltiazolderivater og anvendelse som P13 kinaseinhibitorer | |
DK1713806T3 (da) | Forbindelser og sammensætninger som proteinkinaseinhibitorer | |
DK1997809T3 (da) | P38-inhibitorer og fremgangsmåder til anvendelse deraf | |
IS8037A (is) | P38-hindrar og aðferðir til notkunar þeirra | |
DK1437106T3 (da) | Prøveimplantatsæt | |
NO20053356D0 (no) | Aminindazolderivater og anvendelse derav som kinaseinhibitorer. | |
DK1730146T3 (da) | Azaindoler anvendelige som inhibitorer af JAK og andre proteinkinaser | |
DK1465615T3 (da) | Tricykliske bisenonderivater og fremgangsmåder til anvendelse heraf | |
DK2305250T3 (da) | Benzimidazolderivater og anvendelse heraf som proteinkinaseinhibitorer | |
NO20052888D0 (no) | Diamintriazoler anvendelige som inhibitorer av proteinkinaser | |
DK1756064T3 (da) | Pyrazolderivater, sammensætninger indeholdende sådanne forbindelser og anvendelsesmetoder | |
IS2565B (is) | Aðferðir og lyfjasamsetningar til að ná áreiðanlega ásættanlegum testósterónstyrk í sermi | |
NO20062649L (no) | Biarylsulfonamider og metoder for anvendelse av disse | |
NO20061906L (no) | Terapeutisk middel for mesoteliom | |
DK1527050T3 (da) | Quinolin-derivater og deres anvendelse som mycobakterielle inhibitorer | |
IS7505A (is) | Pýrróló-tríazín anilín efnasambönd gagnleg sem kínasatálmar | |
DK1830926T3 (da) | Oreganomundplejesammensætninger og fremgangsmåde til anvendelse heraf | |
NO20032229L (no) | Fremgangsmåter for behandling av p38kinase-assosierte tilstander og pyrrolotriazin forbindelser nyttige som kinase inhibitorer | |
NO20034187L (no) | Nye spirotricykliske derivater og anvendelse derav som fosfodiesterase-7 inhibitorer | |
NO20054765D0 (no) | Nye probiotiske sammensetninger og fremgangsmater for anvendelse derav | |
NO20050620L (no) | Nye 2-aryltiazol-forbindelser som PPARALPHA og PPARGAMA agonister | |
NO20034944D0 (no) | Re-aktiverte T-celler for adoptiv immunoterapi | |
NO20053874D0 (no) | Formulering og metoder for behandling av thrombocytemi | |
DK2617714T3 (da) | Kemiske derivater af jasmonat, farmaceutiske præparater og fremgangsmåder til anvendelse deraf |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |